Scandion Oncology A/S
https://scandiononcology.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Scandion Oncology A/S
Finance Watch: Prepare For September IPOs To Rebound From August Slowdown
Bookmark
-
Analysis
Renaissance Capital expects an initial public offering surge in September; Biomedtracker data show financings for COVID-19 programs fell from Q1 to Q2; Revelation will merge with a special purpose acquisition corporation; Ascendis netted $379.3m in a follow-on offering; and Disc Medicine raised $90m in venture capital.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
Advertisement
Advertisement